These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27377737)

  • 1. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection in hospitals: risk factors and responses.
    Louie TJ; Meddings J
    CMAJ; 2004 Jul; 171(1):45-6. PubMed ID: 15238495
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and medical management of Clostridium difficile infection.
    Shannon-Lowe J; Matheson NJ; Cooke FJ; Aliyu SH
    BMJ; 2010 Mar; 340():c1296. PubMed ID: 20228142
    [No Abstract]   [Full Text] [Related]  

  • 7. Continued high use of PPIs despite C. difficile risk.
    Brown C
    CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium difficile.
    Baierlein SA; Wistop A
    N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host and pathogen factors for Clostridium difficile infection and colonization.
    Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
    N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dangers of proton pump inhibitor therapy.
    Owen C; Marks DJ; Banks M
    Br J Hosp Med (Lond); 2014 Jul; 75(7):C108-12. PubMed ID: 25152941
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastric acid suppression and Clostridium difficile infection: is there a causal connection?
    Khanna S; Pardi DS
    Clin Gastroenterol Hepatol; 2012 May; 10(5):564; author reply 564. PubMed ID: 22289872
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium difficile infection and colonization.
    Lapane KL; Motzkus-Feagans C; Pakyz A
    N Engl J Med; 2012 Jan; 366(3):276; author reply 276-7. PubMed ID: 22256813
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostridium difficile.
    Della-Torre E; Dagna L; Saporiti N
    N Engl J Med; 2009 Feb; 360(6):637; author reply 637-8. PubMed ID: 19202583
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium difficile infection: managing the risks.
    DeDea L
    JAAPA; 2012 May; 25(5):16. PubMed ID: 22712142
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Abdallah J; Hassan T; Kyprianou A
    Am J Gastroenterol; 2014 Apr; 109(4):601-2. PubMed ID: 24698870
    [No Abstract]   [Full Text] [Related]  

  • 17. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.
    Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY
    J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid suppression and the risk of Clostridium difficile infection.
    Mezoff EA; Cohen MB
    J Pediatr; 2013 Sep; 163(3):627-30. PubMed ID: 23759424
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.